These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2080948)

  • 1. [Antihypertensive therapy with co-dergocrine mesilate/nifedipine in comparison with nifedipine in type II diabetes].
    Janka HU; Mehnert H
    Arzneimittelforschung; 1990 Sep; 40(9):980-3. PubMed ID: 2080948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of co-dergocrine mesilate/nifedipine compared to mefruside/nifedipine on circadian blood pressure in patients with essential hypertension.
    Kirsten R; Heller A; Heintz B; Nelson K
    J Hum Hypertens; 1990 Aug; 4(4):461-4. PubMed ID: 2258894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic consequences of long-term antihypertensive treatment with co-dergocrine mesylate/nifedipine in high age groups].
    Ritter MM; Richter WO; Schwandt P
    Arzneimittelforschung; 1992 Mar; 42(3):311-3. PubMed ID: 1497690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-dergocrine plasma concentrations and blood pressure changes in hypertensive patients during therapy with slow-release co-dergocrine mesylate.
    Woodcock BG; Herrmann W; Habedank WD
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):63-5. PubMed ID: 1551748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
    Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
    Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy comparison between the combination hydergine/nifedipine and nifedipine alone in patients with isolated systolic hypertension].
    Dominiak P; Weidinger G
    Med Klin (Munich); 1991 Jan; 86(1):15-9. PubMed ID: 2017111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM.
    Chan JC; Yeung VT; Leung DH; Tomlinson B; Nicholls MG; Cockram CS
    Diabetes Care; 1994 Aug; 17(8):859-62. PubMed ID: 7956631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonist antihypertensive treatment of non-insulin-dependent diabetics: efficacy and safety of lacidipine versus nifedipine SR.
    Gulizia M; Valenti R; Platania F; D'Onofrio V; Rizzini P; Circo A
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S101-4. PubMed ID: 7609494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of isradipine and nifedipine retard in hypertensive patients with type II diabetes mellitus.
    Gomis R; Vidal J; Novials A; Coves MJ
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):102S-103S. PubMed ID: 8466715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus.
    Chellingsworth MC; Kendall MJ; Wright AD; Singh BM; Pasi J
    J Hum Hypertens; 1989 Feb; 3(1):35-9. PubMed ID: 2657057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
    Crepaldi G; Carraro A; Brocco E; Adezati L; Andreani D; Bompiani G; Brunetti P; Fedele D; Giorgino R; Giustina G
    Acta Diabetol; 1995 Oct; 32(3):203-8. PubMed ID: 8590792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics.
    Baba S;
    Diabetes Res Clin Pract; 2001 Dec; 54(3):191-201. PubMed ID: 11689274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.
    Ohman KP; Weiner L; von Schenck H; Karlberg BE
    Eur J Clin Pharmacol; 1985; 29(2):149-54. PubMed ID: 3908121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
    Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
    Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.
    Ueng KC; Ningling S; El Maksod A; Hung KY; Yuehui Y
    Clin Drug Investig; 2011; 31(9):631-42. PubMed ID: 21591818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
    Juttmann JR; de Vries Robles P; Venuti RP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension caused by low renin: comparison of the calcium antagonist nifedipine and the ACE-inhibitor enalapril as to antihypertensive efficacy].
    Andronico G; Carone MB; Mulè G; Mangano MT; Cerasola G
    Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1161-4. PubMed ID: 2100527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.